Eiger BioPharmaceuticals, Inc.


350 Cambridge Ave, Suite 350, Palo Alto, CA 94306
Phone: 1-877-899-2051 Fax: 650-618-1621

Eiger is a clinical-stage biopharmaceutical company committed to developing and commercializing novel products for the treatment of Orphan diseases.  Eiger has built a diverse, late-stage portfolio of well-characterized product candidates with the potential to address diseases for which the unmet medical need is high, a novel biology for treatment has been identified, and for which an effective therapy is urgently needed.